Sage Journals: Discover world-class research

Retricted access

Research article

First published 2019-10

Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease

Marine Imbert, Florence Blandel, Christian Leumann [...]

Nucleic Acid Therapeutics

Open access

Review article

First published 2023

Implications of Tau Dysregulation in Huntington’s Disease and Potential for New Therapeutics

Isaline Mees, Rebecca M. Nisbet, Anthony J. Hannan [...]

Journal of Huntington's Disease

Open access

Review article

First published 2022-04

Current and Possible Future Therapeutic Options for Huntington’s Disease

Mackenzie W. Ferguson, Connor J. Kennedy, Thulani H. Palpagama [...]

Journal of Central Nervous System Disease

Open access

Article commentary

First published 2019

Raising Awareness of Therapeutic Misconception and Optimism Around Clinical Trials in Huntington’s Disease

Susanne Tamara de Bot

Journal of Huntington's Disease

Free access

Review article

First published 2007-3

Huntington's Disease: Pathological Mechanisms and Therapeutic Strategies

Shilpa Ramaswamy, Kathleen M. Shannon, Jeffrey H. Kordower

Cell Transplantation

Open access

Review article

First published 2013-8

Huntingtin Interactions with Membrane Phospholipids: Strategic Targets for Therapeutic Intervention?

Kimberly B. Kegel-Gleason

Journal of Huntington's Disease

Open access

Review article

First published 2017

Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease

Danielle A. Simmons

Journal of Huntington's Disease

Retricted access

Review article

First published 2021-03

Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease

Lígia Fão, Ana Cristina Rego

Antioxidants & Redox Signaling

Retricted access

Research article

First published 2020-02

Therapeutic Antisense Targeting of Huntingtin

Anne V. Smith, Sarah J. Tabrizi

DNA and Cell Biology

Retricted access

Research article

First published 2010-02

HIF Prolyl Hydroxylase Inhibitors Prevent Neuronal Death Induced by Mitochondrial Toxins: Therapeutic Implications for Huntington's Disease and Alzheimer's Disease

Zoya Niatsetskaya, Manuela Basso, Rachel E. Speer [...]

Antioxidants & Redox Signaling

Search results